MESCHIARI, MARIANNA
 Distribuzione geografica
Continente #
NA - Nord America 13.098
EU - Europa 7.258
AS - Asia 7.210
SA - Sud America 1.099
Continente sconosciuto - Info sul continente non disponibili 268
AF - Africa 197
OC - Oceania 26
Totale 29.156
Nazione #
US - Stati Uniti d'America 12.653
IT - Italia 3.106
SG - Singapore 2.177
CN - Cina 1.644
GB - Regno Unito 1.189
VN - Vietnam 845
HK - Hong Kong 779
BR - Brasile 754
DE - Germania 531
BD - Bangladesh 516
SE - Svezia 511
RU - Federazione Russa 363
FI - Finlandia 350
FR - Francia 311
CA - Canada 261
KR - Corea 235
NL - Olanda 234
ID - Indonesia 189
IN - India 184
AR - Argentina 117
TR - Turchia 98
BG - Bulgaria 84
MX - Messico 78
ES - Italia 77
UA - Ucraina 70
LT - Lituania 67
JP - Giappone 65
ZA - Sudafrica 63
PL - Polonia 58
IQ - Iraq 57
CO - Colombia 56
IR - Iran 53
CL - Cile 47
EC - Ecuador 44
AE - Emirati Arabi Uniti 43
PK - Pakistan 43
IE - Irlanda 40
MY - Malesia 38
AT - Austria 35
CZ - Repubblica Ceca 34
SI - Slovenia 33
MA - Marocco 30
VE - Venezuela 29
BE - Belgio 28
TH - Thailandia 28
AU - Australia 25
CR - Costa Rica 24
CH - Svizzera 22
SA - Arabia Saudita 22
JO - Giordania 21
PH - Filippine 21
UZ - Uzbekistan 19
RO - Romania 18
NP - Nepal 16
EG - Egitto 15
IL - Israele 15
KZ - Kazakistan 15
PE - Perù 15
PY - Paraguay 15
TN - Tunisia 14
GR - Grecia 13
JM - Giamaica 13
BO - Bolivia 12
DO - Repubblica Dominicana 12
KE - Kenya 11
TW - Taiwan 11
DZ - Algeria 10
AZ - Azerbaigian 9
PR - Porto Rico 9
PS - Palestinian Territory 9
AL - Albania 8
HU - Ungheria 8
LV - Lettonia 8
NO - Norvegia 8
SN - Senegal 8
UY - Uruguay 8
BH - Bahrain 7
GE - Georgia 7
OM - Oman 7
SK - Slovacchia (Repubblica Slovacca) 7
SV - El Salvador 7
SY - Repubblica araba siriana 7
DK - Danimarca 6
NG - Nigeria 6
NI - Nicaragua 6
PA - Panama 6
PT - Portogallo 6
SC - Seychelles 6
BY - Bielorussia 5
ET - Etiopia 5
GT - Guatemala 5
HN - Honduras 5
MD - Moldavia 5
TT - Trinidad e Tobago 5
BB - Barbados 4
BZ - Belize 4
CI - Costa d'Avorio 4
CY - Cipro 4
EE - Estonia 4
LB - Libano 4
Totale 28.813
Città #
Ashburn 1.617
Singapore 1.373
Santa Clara 1.346
San Jose 843
Fairfield 779
Hong Kong 750
Southend 653
Chandler 638
Hefei 535
Council Bluffs 490
Nyköping 333
Los Angeles 307
Woodbridge 303
Houston 298
New York 296
Cambridge 291
London 285
Ho Chi Minh City 277
Seattle 275
Helsinki 268
Beijing 265
Seoul 226
Milan 214
Wilmington 213
Dallas 208
Rome 198
Modena 196
Bologna 192
Hanoi 185
Chicago 166
Munich 165
Jakarta 150
San Diego 141
The Dalles 118
Ann Arbor 114
Lauterbourg 100
Shanghai 97
Buffalo 96
Moscow 91
Toronto 78
Princeton 76
São Paulo 71
Atlanta 70
Sofia 70
Naples 69
Frankfurt am Main 67
Boardman 59
Parma 59
Bremen 55
Orem 55
Amsterdam 54
Tokyo 51
Jacksonville 48
Phoenix 48
Warsaw 47
Turku 46
Da Nang 45
Dearborn 43
Montreal 42
Hillsboro 41
North York 38
Palermo 38
Paris 38
Turin 38
Reggio Emilia 37
Salt Lake City 37
Redwood City 36
Florence 35
Brooklyn 33
Fremont 33
Stockholm 33
Johannesburg 31
Columbus 30
Nuremberg 30
Dublin 29
Catania 28
Denver 28
Kent 28
Mumbai 28
Redondo Beach 28
Rio de Janeiro 28
Bari 27
Chennai 27
Haiphong 26
Madrid 26
Mexico City 26
Poplar 25
Santiago 24
Verona 24
Lappeenranta 23
Brussels 22
Portsmouth 22
Rimini 22
San Francisco 22
Belo Horizonte 21
Des Moines 21
Grafing 21
Guangzhou 21
Izmir 21
Biên Hòa 20
Totale 17.411
Nome #
Multidrug-resistant tuberculosis outbreak in an Italian prison: Tolerance of pyrazinamide plus levofloxacin prophylaxis and serial interferon gamma release assays 809
Granulicatella adiacens and Abiotrophia defectiva Native Vertebral Osteomyelitis: Three Cases and Literature Review of Clinical Characteristics and Treatment Approach 707
Ceftazidime-avibactam use for KPC-Kp infections: a retrospective observational multicenter study 568
Cytomegalovirus blood reactivation in COVID-19 critically ill patients: risk factors and impact on mortality. 550
COVID-19-associated vasculitis and thrombotic complications: from pathological findings to multidisciplinary discussion 525
A five-component infection control bundle to permanently eliminate a carbapenem-resistant Acinetobacter baumannii spreading in an intensive care unit 481
T cell activation but not polyfunctionality after primary HIV infection predicts control of viral load and length of the time without therapy. 470
Tocilizumab in patients with severe COVID-19: a retrospective cohort study 469
Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with Covid-19 pneumonia. 447
Development and validation of a prediction model for tocilizumab failure in hospitalized patients with SARS-CoV-2 infection 440
Metabolic reprograming shapes neutrophil functions in severe COVID-19 421
Two fatal cases of acute liver failure due to HSV-1 infection in COVID-19 patients following immunomodulatory therapies. 420
Handling and processing of blood specimens from patients with Covid-19 for safe studies on cell phenotype and cytokine storm 413
Altered bioenergetics and mitochondrial dysfunction of monocytes in patients with COVID-19 pneumonia 408
Better prognosis in females with severe COVID-19 pneumonia: possible role of inflammation as potential mediator. 392
Acute human herpes virus 7 (HHV-7) encephalitis in an immunocompetent adult patient: a case report and review of literature 391
Machine learning in predicting respiratory failure in patients with COVID-19 pneumonia - challenges, strengths, and opportunities in a global health emergency. 389
Antimicrobial stewardship in a Gastroenterology Department: Impact on antimicrobial consumption, antimicrobial resistance and clinical outcome 383
Herpes Simplex re-activation in patients with SARS-CoV2 pneumonia: a prospective observational study. 376
RAAS inhibitors are not associated with mortality in COVID-19 patients: findings from an observational multicenter study in Italy and a meta-analysis of 19 studies 373
Risk factors for pulmonary air leak and clinical prognosis in patients with COVID-19 related acute respiratory failure: a retrospective matched control study. 373
Incidence, risk factors and outcome of acute kidney injury (AKI) in patients with COVID-19 367
Ectopic fat is linked to prior cardiovascular events in men with HIV. 358
Expansion of plasmablasts and loss of memory B cells in peripheral blood from COVID-19 patients with pneumonia 353
Comparison of Patients With or Without COVID-19 and Without Hematological Diseases Treated for Invasive Pulmonary Aspergillosis: A 5-Year Retrospective Cohort Study with Propensity-Based Adjustment 351
Ceftazidime/avibactam and ceftolozane/tazobactam for the treatment of extensively drug-resistant Pseudomonas aeruginosa post-neurosurgical infections: three cases and a review of the literature 348
First and second waves among hospitalised patients with COVID-19 with severe pneumonia: a comparison of 28-day mortality over the 1-year pandemic in a tertiary university hospital in Italy 341
Hypokalemia in Patients with COVID-19 339
Detailed characterization of SARS-CoV-2-specific T and B cells after infection or heterologous vaccination 339
Darunavir/Cobicistat Is Associated with Negative Outcomes in HIV-Negative Patients with Severe COVID-19 Pneumonia 334
Peritoneal dialysis in the time of coronavirus disease 2019 309
The impact of tocilizumab on respiratory support states transition and clinical outcomes in COVID-19 patients. A Markov model multi-state study 308
Aseptic Osteonecrosis: A Newly Diagnosed Complication in HIV-Infected Patients Undergoing Liver Transplantation. 298
Adjunctive Immunotherapy With Polyclonal Ig-M Enriched Immunoglobulins for Septic Shock: From Bench to Bedside. The Rationale for a Personalized Treatment Protocol 298
Changing in the post-surgery infective complications following the shortening of the antibiotic prophylaxis in the patients undergoing skin dermal substitutes reconstruction 291
INTRAVENOUS FOSFOMYCIN IN COMBINATION REGIMENS AS A TREATMENT OPTION FOR DIFFICULT-TO-TREAT INFECTIONS DUE TO MULTIDRUG-RESISTANT GRAM-NEGATIVE ORGANISMS: A REAL-LIFE EXPERIENCE 290
A Fatal Case of Pseudomonas aeruginosa Community-Acquired Pneumonia in an Immunocompetent Patient: Clinical and Molecular Characterization and Literature Review 280
Effects of cytokine blocking agents on hospital mortality in patients admitted to ICU with acute respiratory distress syndrome by SARS-CoV2 infection: retrospective cohort study. 279
Epidemiology and Outcomes of Bloodstream Infections in HIV-Patients during a 13-Year Period 273
Immunomodulation for the management of severe SARS-CoV2 infections. State of the art and review of the literature 272
Infective complications in patients undergoing surgical reconstruction with dermal matrix: the Modena experience 271
Advances and Challenges in Sepsis Management: Modern Tools and Future Directions 268
Pneumocystosis as a Complication of H1N1 Influenza A Infection in an HIV-Positive Patient on Effective cART 257
Epidemiology and Risk Factors Associated with Mortality in Consecutive Patients with Bacterial Bloodstream Infection: Impact of MDR and XDR Bacteria 257
Disentangling the association of hydroxychloroquine treatment with mortality in covid-19 hospitalized patients through hierarchical clustering 255
Long-Term Suppressive Therapeutic-Drug-Monitoring-Guided Dalbavancin Therapy for Cardiovascular Prosthetic Infections 250
Endogenous control of inflammation characterizes pregnant women with asymptomatic or paucisymptomatic SARS-CoV-2 infection 250
Metabolic-Associated Fatty Liver Disease Is Highly Prevalent in the Postacute COVID Syndrome. 250
Ceftazidime/Avibactam in Ventilator-Associated Pneumonia Due to Difficult-to-Treat Non-Fermenter Gram-Negative Bacteria in COVID-19 Patients: A Case Series and Review of the Literature 246
A retrospective whole-genome sequencing analysis of carbapenem and colistin-resistant klebsiella pneumoniae nosocomial strains isolated during an MDR surveillance program 244
A proof-of-concept study on the genomic evolution of Sars-Cov-2 in molnupiravir-treated, paxlovid-treated and drug-naïve patients 243
Treating cancer with immunotherapy in HIV-positive patients: A challenging reality 238
Surfactant replacement might help recovery of low-compliance lung in severe COVID-19 pneumonia. 236
Comparison of two perioperative antibiotic schedules in patients undergoing surgical reconstruction with dermal matrix after excision of skin cancer 235
Risk factors for nosocomial rectal colonization with carbapenem-resistant Acinetobacter baumannii in hospital: a matched case–control study 235
Treatment of infections caused by multidrug-resistant Gram-negative bacilli: a practical approach by the Italian (SIMIT) and French (SPILF) Societies of Infectious Diseases 230
Long-Term Impact of the COVID-19 Pandemic on In-Hospital Antibiotic Consumption and Antibiotic Resistance: A Time Series Analysis (2015-2021) 230
Ceftolozane/Tazobactam for Treatment of Severe ESBL-Producing Enterobacterales Infections: A Multicenter Nationwide Clinical Experience (CEFTABUSE II Study) 229
The association of procalcitonin and C- reactive protein with bacterial infections acquired during ICU stay in COVID-19 critically ill patients. 221
Is It Possible to Eradicate Carbapenem-Resistant Acinetobacter baumannii (CRAB) from Endemic Hospitals? 220
Awaiting a cure for COVID-19: therapeutic approach in patients with different severity levels of COVID-19 220
Prognostic immune markers identifying patients with severe COVID-19 who respond to tocilizumab 219
Association Between Pulmonary Aspergillosis And Cytomegalovirus Reactivation In Critically Ill Covid-19 Patients: A Prospective Observational Cohort Study. 215
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study 215
Combined resistance to ceftolozane-tazobactam and ceftazidime-avibactam in extensively drug-resistant (Xdr) and multidrug-resistant (mdr) pseudomonas aeruginosa: Resistance predictors and impact on clinical outcomes besides implications for antimicrobial stewardship programs 215
Development of post-COVID-19 cardiovascular events: An analysis of clinical features and risk factors from a single hospital retrospective study 214
Do All Critically Ill Patients with COVID-19 Disease Benefit from Adding Tocilizumab to Glucocorticoids? A Retrospective Cohort Study 212
Real-life experience with compassionate use of cefiderocol for difficult-to-treat resistant Pseudomonas aeruginosa (DTR-P) infections 209
Pneumocystis jirovecii pneumonia in patients with decompensated cirrhosis: a case series 207
Heparin in COVID-19 Patients Is Associated with Reduced In-Hospital Mortality: The Multicenter Italian CORIST Study 206
Critical COVID-19 Patients Through First, Second And Third Wave: Retrospective Observational Study Comparing Outcomes In ICU. 205
Association between respiratory distress time and invasive mechanical ventilation in COVID-19 patients: a multicentre regional cohort study. 205
Assessing ChatGPT’s theoretical knowledge and prescriptive accuracy in bacterial infections: a comparative study with infectious diseases residents and specialists 197
Role of selective digestive decontamination in the prevention of VAP in COVID-19 patients: a pre-post observational study. 194
Clinical Experience with Ceftazidime-Avibactam for the Treatment of Infections due to Multidrug-Resistant Gram-Negative Bacteria Other than Carbapenem-Resistant Enterobacterales 189
The role of antimicrobial stewardship in preventing KPC-producing Klebsiella pneumoniae 185
96 week follow-up of HIV-infected patients in rescue with raltegravir plus optimized backbone regimens: A multicentre Italian experience 180
Hospital-Acquired Infections in Critically Ill Patients With COVID-19 177
Fusobacterium necrophorum septic arthritis of the hip: a case-report and literature review 176
Perioperative Use of IgM-Enriched Immunoglobulins in Liver Transplantation Recipients at High Risk for Infections: A Preliminary Study 174
A rare case of necrotizing fasciitis of the leg in an intravenous drug user caused by Prevotella denticola 171
Therapeutic strategies for severe COVID-19: a position paper from the Italian Society of Infectious and Tropical Diseases (SIMIT) 171
External Validity of a Randomized Controlled Trial on Duration of Antibiotics for the Treatment of Gram-Negative Bacteremia 170
Epidemiology and Prevention of Early Infections by Multi-Drug-Resistant Organisms in Adults Undergoing Liver Transplant: A Narrative Review 169
Impact of VRE-active perioperative prophylaxis in liver transplant patients colonized by Vancomycin-Resistant Enterococci 168
A time-series analysis approach to quantify change in antibiotic resistance and antibiotic consumption during COVID-19 Epidemics: a multicenter cross-national ecological study on behalf of QUARANTINE (QUantifying change in Antibiotic Resistance, ANTibiotic use, and INfection control during COVID-19 Epidemics) study project 167
Development and validation of a prediction model for severe respiratory failure in hospitalized patients with SARS-Cov-2 infection: a multicenter cohort study (PREDI-CO study) 167
Risk factors for functional decline among survivors of Gram-negative bloodstream infection: A prospective cohort study 167
Twenty-four-hour serum creatinine variation is associated with poor outcome in the novel coronavirus disease 2019 (COVID-19) patients 164
Clinical characteristics, therapy and outcome of bloodstream infections caused by vancomycin-resistant enterococci: a multicentre clinical experience 163
Continued decay of HIV proviral DNA upon vaccination with HIV-1 Tat of subjects on long-term ART: An 8-year follow-up study 155
Compassionate use of meropenem/vaborbactam for infections caused by KPC-producing Klebsiella pneumoniae: a multicentre study 149
Efficacy of bezlotoxumab in preventing recurrence of Clostridioides difficile infection: an Italian multicenter cohort study 147
First Human Case of Tick-Borne Encephalitis in Non-Endemic Region in Italy: A Case Report 139
The Impact of COVID-19 on UNAIDS 90-90-90 Targets: Calls for New HIV Care Models 137
Streptococcus equi Subspecies zooepidemicus Endocarditis and Meningitis in a 62-Year-Old Horse Rider Patient: A Case Report and Literature Review 136
New Antibiotics for Staphylococcus aureus Infection: An Update from the World Association of Infectious Diseases and Immunological Disorders (WAidid) and the Italian Society of Anti-Infective Therapy (SITA) 134
Tocilizumab for severe COVID-19 pneumonia – Authors' reply 133
Persistent SARS-CoV-2 infection with multiple clinical relapses in two patients with follicular lymphoma treated with bendamustine and obinutuzumab or rituximab 131
Knowledge, practices, educational needs and hospital engagement in Infection Prevention and Control (IPC) among Italian healthcare workers and students: results from a national multicentre survey 122
Totale 27.772
Categoria #
all - tutte 118.239
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 118.239


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.938 0 0 167 69 114 148 266 122 232 160 406 254
2022/20232.405 272 293 195 215 238 272 74 203 278 71 140 154
2023/20242.281 89 135 163 194 374 222 174 256 104 105 181 284
2024/20255.528 198 120 133 389 909 874 444 328 610 312 551 660
2025/202611.271 822 503 897 1.225 1.407 589 1.338 592 1.117 1.149 926 706
2026/20272.268 501 1.610 157 0 0 0 0 0 0 0 0 0
Totale 29.156